Armiyaw Sebastian Nasamu

Armiyaw Sebastian Nasamu

Auto-generated profile, based on publicly available information

Armiyaw Sebastian Nasamu

Departments of Medicine and Molecular Microbiology, Washington University School of Medicine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Cell
Verified
Journal Article
Closed access
SSSaima M. Sidik
Saima M. Sidik
DHDiego Huet
Diego Huet
SGSuresh M. Ganesan
Suresh M. Ganesan
MHMy-Hang Huynh
My-Hang Huynh
TWTim Wang
Tim Wang
SLSebastian Lourido
Sebastian Lourido

1 March 2016 in Nature Communications
Verified
Journal Article
Open access
SGSuresh M. Ganesan
Suresh M. Ganesan
AFAlejandra Falla
Alejandra Falla
SGStephen J. Goldfless
Stephen J. Goldfless
ANArmiyaw S. Nasamu
Armiyaw S. Nasamu
JNJacquin C. Niles
Jacquin C. Niles
Synthetic posttranscriptional regulation of gene expression is important for understanding fundamental biology and programming new cellular processes in synthetic biology. Previous strategies for regulating translation in eukaryotes have focused on disrupting individual steps in translation, including initiation and mRNA cleavage. In emphasizing modularity and cross-organism functionality, these systems are designed to operate orthogonally to native control mechanisms. Here we introduce a broadly applicable strategy for robustly controlling protein translation by integrating synthetic translational control via a small-molecule-regulated RNA–protein module with native mechanisms that simultaneously regulate multiple facets of cellular RNA fate. We demonstrate that this strategy reduces ‘leakiness’ to improve overall expression dynamic range, and can be implemented without sacrificing modularity and cross-organism functionality. We illustrate this in Saccharomyces cerevisae and the non-model human malarial parasite, Plasmodium falciparum. Given the limited functional genetics toolkit available for P. falciparum, we establish the utility of this strategy for defining essential genes.

27 October 2017 in Science
Verified
Journal Article
Open access
PDF file
ANArmiyaw S. Nasamu
Armiyaw S. Nasamu
SGSvetlana Glushakova
Svetlana Glushakova
IRIlaria Russo
Ilaria Russo
BVBarbara Vaupel
Barbara Vaupel
AOAnna Oksman
Anna Oksman
DGDaniel E. Goldberg
Daniel E. Goldberg
Plasmodium parasite entrance and exit: Sweats and fever are the hallmarks of malaria. Red blood cells are the replication factories for malaria parasites. Fever occurs when the parasites' merozoite stages burst en masse from red blood cells into the circulation. Nasamu et al. and Pino et al. discovered that two parasite proteases, plasmepsin IX and X, are essential for mass cell exit (see the Perspective by Boddey). Plasmepsin X is also used by the merozoites to enter a fresh red blood cell to continue the replicative cycle. These two plasmepsins act by regulating the maturation of enzymes required to disrupt host cell membranes. Because these functions are essential for the parasite, the authors used protease inhibitors to show that plasmepsins provide potential drug targets. Science , this issue p. 518 , p. 522 ; see also p. 445

27 August 2018 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
MGMatthias Garten
Matthias Garten
ANArmiyaw S. Nasamu
Armiyaw S. Nasamu
JNJacquin C. Niles
Jacquin C. Niles
JZJoshua Zimmerberg
Joshua Zimmerberg
DGDaniel E. Goldberg
Daniel E. Goldberg
JBJosh R. Beck
Josh R. Beck
Intraerythrocytic malaria parasites reside within a parasitophorous vacuolar membrane (PVM) generated during host cell invasion1. Erythrocyte remodelling and parasite metabolism require the export of effector proteins and transport of small molecules across this barrier between the parasite surface and host cell cytosol2,3. Protein export across the PVM is accomplished by the Plasmodium translocon of exported proteins (PTEX) consisting of three core proteins, the AAA+ ATPase HSP101 and two additional proteins known as PTEX150 and EXP24. Inactivation of HSP101 and PTEX150 arrests protein export across the PVM5,6, but the contribution of EXP2 to parasite biology is not well understood7. A nutrient permeable channel in the PVM has also been characterized electrophysiologically, but its molecular identity is unknown8,9. Here, using regulated gene expression, mutagenesis and cell-attached patch-clamp measurements, we show that EXP2, the putative membrane-spanning channel of PTEX4,10,11,12,13,14, serves dual roles as a protein-conducting channel in the context of PTEX and as a channel able to facilitate nutrient passage across the PVM independent of HSP101. Our data suggest a dual functionality for a channel operating in its endogenous context.

17 July 2014 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ACAngeliki Chalkiadaki
Angeliki Chalkiadaki
MIMasaki Igarashi
Masaki Igarashi
ANArmiyaw Sebastian Nasamu
Armiyaw Sebastian Nasamu
JKJovana Knezevic
Jovana Knezevic
LGLeonard Guarente
Leonard Guarente
SIRT1 is a metabolic sensor and regulator in various mammalian tissues and functions to counteract metabolic and age-related diseases. Here we generated and analyzed mice that express SIRT1 at high levels specifically in skeletal muscle. We show that SIRT1 transgenic muscle exhibits a fiber shift from fast-to-slow twitch, increased levels of PGC-1α, markers of oxidative metabolism and mitochondrial biogenesis, and decreased expression of the atrophy gene program. To examine whether increased activity of SIRT1 protects from muscular dystrophy, a muscle degenerative disease, we crossed SIRT1 muscle transgenic mice to mdx mice, a genetic model of Duchenne muscular dystrophy. SIRT1 overexpression in muscle reverses the phenotype of mdx mice, as determined by histology, creatine kinase release into the blood, and endurance in treadmill exercise. In addition, SIRT1 overexpression also results in increased levels of utrophin, a functional analogue of dystrophin, as well as increased expression of PGC-1α targets and neuromuscular junction genes. Based on these findings, we suggest that pharmacological interventions that activate SIRT1 in skeletal muscle might offer a new approach for treating muscle diseases. Skeletal muscle has a central role in body posture, mobility and whole-body metabolism. SIRT1 is an enzyme expressed in skeletal muscle, as well as in most mammalian tissues, and has been shown to sense metabolic cues from the environment and mediate changes in these tissues, counteracting age and metabolic diseases. Here we generated and studied mice that express high levels of SIRT1 in skeletal muscle. We found that increased levels of SIRT1 in skeletal muscle led to gene expression changes similar to those that normally occur with endurance exercise. We also observed that SIRT1 overexpression counteracts muscle atrophy, a hallmark of aging muscle, and the muscle degenerative disease Duchenne muscular dystrophy (DMD). DMD is a debilitating disease caused by a mutation in the structural protein dystrophin. SIRT1 overexpression ameliorated the pathophysiology of DMD disease in a mouse model. Our results offer the hope that drugs that constitutively activate the enzymatic activity of SIRT1 might be used to cure muscle degenerative diseases.

13 June 2018 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
SGSvetlana Glushakova
Svetlana Glushakova
JBJosh R. Beck
Josh R. Beck
MGMatthias Garten
Matthias Garten
BBBrad L. Busse
Brad L. Busse
ANArmiyaw S. Nasamu
Armiyaw S. Nasamu
JZJoshua Zimmerberg
Joshua Zimmerberg